Higher the dose, more the relief: It's all a myth says study

Image
ANI
Last Updated : Feb 06 2020 | 11:30 AM IST

According to a recent study conducted over higher dose intake of opioid, it has been observed that such measures are not effective in reducing pain.

The researchers' team from Central Arkansas and Minneapolis VA health care systems and three universities suggest after studying available data that patients who got their opioid dosage increased were not helped by the higher dosage compared to those who continued with earlier dosage.

The Veterans Affairs study looked at prescribing data of more than 50,000 VA patients taking opioids. The findings led the study authors to warn, "Clinicians should exercise extreme caution when embarking on a path of increasing opioid doses to manage non-cancer pain."

The results were published in the January 9, issue of the journal 'Pain'.

A companion study by the same team that appeared online on January 15, in addition, confirmed the increased risk of side effects from higher doses.

Lead author Dr. Corey Hayes in a University of Arkansas for Medical Sciences report said, "You don't see the benefit, but you do see the risk. Our overall message is when you're thinking about increasing the dose, you need to realize the risk it brings, too."

Opioid medications relieve pain. They reduce the intensity of pain signals in the brain and affect areas of the brain controlling emotion, which diminishes the effects of pain stimuli. While opioids can help manage pain when taken correctly, they have a high risk of abuse and addiction.

Patients often receive increased doses of opioid medication because their pain may not be well-controlled on lower doses. People can also develop a tolerance to opioids over time, meaning a higher dose is needed to get the same effects. In these cases, prescribers must weigh the risks and rewards of escalating a patient's opioid dose.

Moreover, higher opioid doses can lead to a variety of side effects, such as constipation, dizziness, increased sensitivity to pain, and increased risk of substance use disorder.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 06 2020 | 11:16 AM IST

Next Story